Results 11 to 20 of about 9,288,830 (350)
Metabolomic rewiring promotes endocrine therapy resistance in breast cancer [PDF]
Approximately one-third of endocrine-treated women with estrogen receptor-alpha positive (ER+) breast cancers (BC) are at risk of recurrence due to intrinsic or acquired resistance.
Songyeon Ahn +10 more
semanticscholar +2 more sources
Simple Summary Many persons diagnosed with breast cancer are treated with endocrine therapy and will experience the side effects of endocrine therapy. Cognitive adverse effects of endocrine therapy are increasingly being recognised, and can significantly
L. Haggstrom +5 more
semanticscholar +2 more sources
CDK4/6 inhibitors in combination with endocrine therapy has shown efficacy in ER + breast cancer patients but resistance can occur. Here, the authors demonstrate that co-targeting CDK4/6 and AKT with endocrine therapy prevents acquired resistance and ...
Carla L. Alves +13 more
doaj +2 more sources
Primary endocrine therapy of locally advanced breast cancer patients [PDF]
Primary endocrine therapy has been traditionally reserved for elderly and unfit locally advanced breast cancer patients (LABC patients). In this group, the primary endocrine therapy could not be adequately compared to primary chemotherapy.
Nešković-Konstantinović Zora B.
doaj +2 more sources
Pin Gao,1 Lili You,2 Di Wu,1 Aiping Shi,1 Qing Miao,3 Ujala Rana,4 Dustin Paul Martin,3 Ye Du,1 Gang Zhao,1 Bing Han,1 Chao Zheng,5 Zhimin Fan1 1Department of Breast Surgery, First Hospital of Jilin University, Changchun, Jilin, China; 2Department of ...
Gao P +11 more
doaj +1 more source
Jessica Keim-Malpass,1 Aubrey Doede,1 Shayna L Showalter2 1Department of Acute and Specialty Care, University of Virginia School of Nursing, Charlottesville, VA 22908, USA; 2Department of Surgery, University of Virginia School of Medicine ...
Keim-Malpass J, Doede A, Showalter SL
doaj +1 more source
Prashant Kaduskar, K M Suryanarayana
doaj +3 more sources
The potential of chimeric antigen receptor -T cell therapy for endocrine cancer
Endocrine cancer, a relatively rare and heterogeneous tumor with diverse clinical features. The facile synthesis of hormones further complicates endocrine cancer treatment.
Ruonan Yu +5 more
doaj +2 more sources
Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours
ER/PR+HER2- breast tumours are the most predominant subtype of breast cancer worldwide, including India. Unlike TNBCs, these tumours can be treated with anti-estrogens or aromatase inhibitors.
Arnab Ghosh +8 more
doaj +2 more sources
SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy. [PDF]
Immunotherapy treatment with checkpoint inhibitors (CPI) (CTLA-4 and PD-1 inhibitors) significantly improves survival in a number of cancers. Treatment can be limited by immune-mediated adverse effects including endocrinopathies such as hypophysitis ...
Cooksley, T +8 more
core +2 more sources

